$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study

European journal of radiology, v.105, 2018년, pp.96 - 101  

Francica, Giampiero (Interventional Ultrasound Unit, Pineta Grande Hospital) ,  Meloni, Maria Franca (Department of Interventional Ultrasound, Institute of Care Igea) ,  Riccardi, Laura (Department of Internal Medicine and Gastroenterology, Catholic University of Sacred Heart) ,  de Sio, Ilario (Department of Hepatogastroenterology, Università) ,  Terracciano, Fulvia (degli Studi della Campania Luigi Vanvitelli) ,  Caturelli, Eugenio (IRCSS Casa Sollievo della Sofferenza, Gastroenterology) ,  Iadevaia, Maddalena Diana (Gastroenterology Unit, Belcolle Hospital) ,  Amoruso, Annabianca (Department of Hepatogastroenterology, Università) ,  Roselli, Paola (degli Studi della Campania Luigi Vanvitelli) ,  Chiang, Jason (IRCSS Casa Sollievo della Sofferenza, Gastroenterology) ,  Scaglione, Mariano (Gastroenterology Unit, Belcolle Hospital) ,  Pompili, Maurizio (Department of Radiology, Ronald Reagan UCLA Medical Center)

Abstract AI-Helper 아이콘AI-Helper

Abstract The present retrospective study was aimed at characterizing the clinical impact of contrast-enhanced ultrasound (CEUS) as a guidance technique for ablation of primary and secondary liver tumors at six interventional ultrasound centers. 148 patients (103M/45F, median age 74 yrs.) with 151 l...

주제어

참고문헌 (33)

  1. CA Cancer J. Clin. Torre 65 87 2015 10.3322/caac.21262 Global cancer statistics, 2012 

  2. Ferlay 2013 GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 

  3. Gut Benvegnu 53 744 2004 10.1136/gut.2003.020263 Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications 

  4. Hepatology Bruix 1020 2011 10.1002/hep.24199 Management of hepatocellular carcinoma: an update 

  5. International Agency for Research on Cancer : World Health Organization. GLOBOCAN 2012 Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012 

  6. HPB Oxf. Adams 15 91 2013 10.1111/j.1477-2574.2012.00557.x Selection for hepatic resection of colorectal liver metastases: expert consensus statement 

  7. Radiology Lencioni 262 43 2012 10.1148/radiol.11110144 Loco-regional treatment of hepatocellular carcinoma 

  8. Radiology Mahnken 266 407 2013 10.1148/radiol.12112544 Interventional oncologic approaches to liver metastases 

  9. J. Hepatol. 56 908 2012 10.1016/j.jhep.2011.12.001 European Association for the Study of the Liver; European organisation for Research and Treatment of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma 

  10. Eur. Radiol. Gillams 25 3438 2015 10.1007/s00330-015-3779-z Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology Sans Frontieres meeting 2013 

  11. Eur. Radiol. Quaia 16 1599 2006 10.1007/s00330-006-0192-7 Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence 

  12. J. Ultrasound Med. Lee 30 607 2011 10.7863/jum.2011.30.5.607 Percutaneous sonographically guided radiofrequency ablation of hepatocellular carcinoma: causes of mistargeting and factors affecting the feasibility of a second ablation session 

  13. Cancer Goldberg 88 2452 2000 10.1002/1097-0142(20000601)88:11<2452::AID-CNCR5>3.0.CO;2-3 Treatment of intrahepatic malignancy with radio-frequency ablation: radiologic-pathologic correlation 

  14. Eur. J. Radiol. Clasen 59 140 2006 10.1016/j.ejrad.2006.04.006 Magnetic resonance imaging for hepatic radiofrequency ablation 

  15. Eur. J. Radiol. Clasen 83 111 2014 10.1016/j.ejrad.2013.09.018 Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? 

  16. Clin. Radiol. Xu 67 447 2012 10.1016/j.crad.2011.10.015 Magnetic navigation in ultrasound-guided interventional radiology procedures 

  17. Cardiovasc. Intervent. Radiol. Mauri 238 143 2015 10.1007/s00270-014-0897-y Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases 

  18. Ultrasound Med. Biol. Claudon 39 187 2013 10.1016/j.ultrasmedbio.2012.09.002 

  19. Lorentzen 36 E1 2015 EFSUMB guidelines on Interventional Ultrasound (INVUS) 

  20. Ultraschall Med. Lorentzen 32 492 2011 10.1055/s-0029-1246002 Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients 

  21. Int. J. Hyperth. Liu 27 555 2011 10.3109/02656736.2011.564262 Contrast-enhanced ultrasound-guided microwave ablation for hepatocellular carcinoma inconspicuous on conventional ultrasound 

  22. J. Vasc. Interv. Radiol. Ahmed 25 1706 2014 10.1016/j.jvir.2014.09.005 Technology assessment committee of the society of interventional radiology. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update: supplement to the consensus document 

  23. J. Vasc. Interv. Radiol. Omary 14 S293 2003 10.1097/01.RVI.0000094601.83406.e1 Society of interventional radiology standards of practice committee 

  24. J. Gastroenterol. Hepatol. Masuzaki 26 759 2011 10.1111/j.1440-1746.2010.06559.x Utility of contrast-enhanced ultrasonography with sonazoid in radiofrequency ablation for hepatocellular carcinoma 

  25. Insights Imaging Mauri 5 209 2014 10.1007/s13244-014-0315-7 Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment 

  26. Radiographics Huang 37 652 2017 10.1148/rg.2017160123 Contrast-enhanced US-guided interventions: improving success rate and avoiding complications using US contrast agents 

  27. Am. J. Roentgenol. Rhim 190 1324 2008 10.2214/AJR.07.2970 Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas 

  28. J. Hepatol. Ahn 66 347 2017 10.1016/j.jhep.2016.09.003 Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma 

  29. Ultrasonography Lee 33 227 2014 10.14366/usg.14021 Fusion imaging of real-time ultrasonography with CT or MRI for hepatic intervention 

  30. Eur. J. Radiol. Meloni 81 e897 2012 10.1016/j.ejrad.2012.05.002 Contrast enhanced ultrasound: should it play a role in immediate evaluation of liver tumors following thermal ablation 

  31. Anticancer Res. Pompili 35 325 2015 Single hepatocellular carcinoma smaller than 2 cm: are ethanol injection and radiofrequency ablation equally effective? 

  32. Gastroenterology Lin 127 1714 2004 10.1053/j.gastro.2004.09.003 Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm 

  33. Gastroenterology Shiina 129 122 2005 10.1053/j.gastro.2005.04.009 A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로